ALAM JOHN J
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to ALAM JOHN J. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| CRVO | CEO & President | Purchase | 10,793 | $8.46 | $91,309 | Nov 17, 2025 |
| CRVO | CEO & President | Purchase | 4,447 | $7.51 | $33,397 | Nov 14, 2025 |
| CRVO | CEO & President | Purchase | 5,553 | $7.35 | $40,815 | Nov 12, 2025 |
| CRVO | CEO & President | Gift | 12,500 | — | — | Nov 9, 2023 |
| VRTX | EVP, Med. Dev. Group & CMO | Option Exercise | 4,253 | $13.63 | $57,968 | Oct 1, 2008 |
| VRTX | EVP, Med. Dev. Group & CMO | Option Exercise | 6,614 | $10.19 | $67,397 | Sep 10, 2008 |
| VRTX | EVP, Med. Dev. Group & CMO | Sale | 6,612 | $25.86 | $170,986 | Sep 3, 2008 |
| VRTX | EVP, Med. Dev. Group & CMO | Sale | 6,612 | $27.02 | $178,656 | Aug 27, 2008 |
| VRTX | EVP, Med. Dev. Group & CMO | Sale | 1,920 | $27.99 | $53,741 | Aug 20, 2008 |
| VRTX | EVP, Med. Dev. Group & CMO | Option Exercise | 3,459 | $15.60 | $53,960 | Jun 19, 2008 |
| VRTX | EVP, Med. Dev. Group & CMO | Sale | 80 | $27.71 | $2,217 | May 20, 2008 |
| VRTX | EVP, Med. Dev. Group & CMO | Award / Grant | 9,667 | $0.01 | $97 | Feb 7, 2008 |
| VRTX | EVP, Medicines Dev. & CMO | Sale | 50 | $25.57 | $1,279 | Dec 11, 2007 |
| VRTX | EVP, Medicines Dev. & CMO | Sale | 1 | $25.82 | $26 | Nov 16, 2007 |
| VRTX | EVP, Medicines Dev. & CMO | Option Exercise | 1,966 | $18.47 | $36,312 | Aug 6, 2007 |
| VRTX | EVP, Medicines Dev. & CMO | Sale | 794 | $31.95 | $25,368 | May 17, 2007 |
| VRTX | EVP, Medicines Dev. & CMO | Option Exercise | 3,188 | $13.63 | $43,452 | May 7, 2007 |
| VRTX | EVP, Medicines Dev., & CMO | Sale | 500 | $35.46 | $17,730 | Jan 31, 2007 |
| VRTX | EVP, Med. Product Dev. & CMO | Option Exercise | 1,000 | $18.47 | $18,470 | Jan 24, 2007 |
| VRTX | EVP, Medicines Dev., & CMO | Sale | 500 | $38.29 | $19,145 | Jan 17, 2007 |
| VRTX | EVP, Medicines Dev., & CMO | Sale | 1,000 | $35.00 | $35,000 | Jan 10, 2007 |
| VRTX | SVP, Drug Eval. & Appr. | Sale | 1,000 | $37.12 | $37,120 | Jan 3, 2007 |
| VRTX | SVP, Drug Eval. & Appr. | Option Exercise | 500 | $9.07 | $4,535 | Dec 27, 2006 |
| VRTX | SVP, Drug Eval. & Appr. | Option Exercise | 500 | $9.07 | $4,535 | Dec 20, 2006 |
| VRTX | EVP, Medicines Dev. & CMO | Sale | 480 | $38.85 | $18,648 | Dec 13, 2006 |
| VRTX | EVP, Medicines Dev. & CMO | Sale | 1,500 | $38.54 | $57,810 | Dec 13, 2006 |
| VRTX | EVP, Medicines Dev. & CMO | Sale | 1,500 | $44.69 | $67,035 | Dec 6, 2006 |
| VRTX | EVP, Medicines Dev. & CMO | Option Exercise | 1,000 | $18.47 | $18,470 | Nov 29, 2006 |
| VRTX | EVP, Med. Dev. Group & CMO | Sale | 1,500 | $44.36 | $66,540 | Nov 22, 2006 |
| VRTX | EVP, Med. Dev. Group & CMO | Option Exercise | 1,500 | $18.47 | $27,705 | Nov 15, 2006 |
| VRTX | EVP, Med. Dev. Group & CMO | Option Exercise | 1,500 | $18.47 | $27,705 | Nov 8, 2006 |
| VRTX | EVP, Med. Dev. Group & CMO | Option Exercise | 3,000 | $18.47 | $55,410 | Nov 1, 2006 |
| VRTX | EVP, Med. Dev. Group & CMO | Option Exercise | 1,500 | $18.47 | $27,705 | Oct 18, 2006 |
| VRTX | EVP, Med. Dev. Group & CMO | Sale | 7,500 | $35.35 | $265,125 | Oct 11, 2006 |
| VRTX | EVP, Med. Dev. Group & CMO | Option Exercise | 1,500 | $18.47 | $27,705 | Sep 6, 2006 |
| VRTX | EVP, Med. Dev. Group & CMO | Sale | 7,500 | $35.00 | $262,500 | Aug 30, 2006 |
| VRTX | EVP, Med. Product Dev. & CMO | Award / Grant | 12,200 | $0.01 | $122 | Feb 2, 2006 |